Treating glioblastoma patients with poor performance status: where do we go from here?

by Pérez-Larraya, Jaime Gállego, Ducray, François
Published in CNS Oncol (2014)

Treating glioblastoma in the elderly

by Pérez-Larraya, Jaime Gállego, Delattre, Jean-Yves
Published in CNS Oncol (2012)

Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

by Pérez-Larraya, Jaime Gállego, Lahutte, Marion, Petrirena, Gregorio, Reyes-Botero, Germán, González-Aguilar, Alberto, Houillier, Caroline, Guillevin, Rémy, Sanson, Marc, Hoang-Xuan, Khê, Delattre, Jean-Yves
Published 2012

IMMU-09. MODULATING THE MYELOID POPULATION IN DIPG MODELS WITH ONCOLYTIC VIRUS AND COMPLEMENT INHIBITORS SHOWS THERAPEUTIC EFFICACY

by Puigdelloses, Montserrat, Laspidea, Virginia, Hambardzumyan, Dolores, Chen, Zhihong, Gupta, Sumit, Gomez-Manzano, Candelaria, Labiano, Sara, Becher, Oren J, Woodruff, Trent, Pío, Ruben, Ajona, Daniel, Pérez-Larraya, Jaime Gállego, Alonso, Marta M
Published in Neuro Oncol (2021)

CBMT-19. RNU6-1 ANALYSED IN EXOSOMES FROM SERA AS A NOVEL DIFFERENTIAL BIOMARKER FOR GBM VS NON-NEOPLASTIC BRAIN LESIONS AND NSCPL

by Vallcorba, Montserrat Puigdelloses, Varela-Guruceaga, Maider, González-Huarriz, Marisol, Zandio, Beatriz, Besora, Sarah, Bruna, Jordi, Petrirena, Gregorio, Marigil, Miguel, Díez-Valle, Ricardo, Tejada, Sonia, Nuñez, Jorge, Alonso, Marta M, Pérez-Larraya, Jaime Gállego
Published in Neuro Oncol (2018)

Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

by Jablonska, Paola Anna, Diez-Valle, Ricardo, Pérez-Larraya, Jaime Gállego, Moreno-Jiménez, Marta, Idoate, Miguel Ángel, Arbea, Leire, Tejada, Sonia, Garcia de Eulate, Maria Reyes, Ramos, Luis, Arbizu, Javier, Domínguez, Pablo, Aristu, José Javier
Published in PLoS One (2019)

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

by Inogés, Susana, Tejada, Sonia, de Cerio, Ascensión López-Díaz, Pérez-Larraya, Jaime Gállego, Espinós, Jaime, Idoate, Miguel Angel, Domínguez, Pablo Daniel, de Eulate, Reyes García, Aristu, Javier, Bendandi, Maurizio, Pastor, Fernando, Alonso, Marta, Andreu, Enrique, Cardoso, Felipe Prósper, Valle, Ricardo Díez
Published in J Transl Med (2017)

CBIO-06. POTENTIAL ROLE OF RNU6 ISOLATED FROM CIRCULATING EXOSOMES AS A DIAGNOSTIC BIOMARKER FOR GLIOBLASTOMA

by Puigdelloses, Montserrat, González-Huarriz, Marisol, Garcia-Moure, Marc, Martínez-Vélez, Naiara, Besora, Sarah, Escuer, Jordi Bruna, Zandio, Beatriz, Ayuso, Teresa, Otano, María, Culleré, Jaime Gallego, Martínez-Vila, Eduardo, Patiño-Garcia, Ana, Sanchez, Miguel Marigil, Valle, Ricardo Diez, Tejada, Sonia, Alonso, Marta M, Pérez-Larraya, Jaime Gallego
Published in Neuro Oncol (2017)

EPCT-04. RESULTS OF A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 WITH RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

by Garcia-Moure, Marc, Pérez-Larraya, Jaime Gállego, Patiño, Ana, Gonzalez-Huarriz, Marisol, Jones, Chris, MacKay, Alan, Van der Lugt, Jasper, Hulleman, Esther, de Andrea, Carlos, Astigarraga, Itziar, García-Ariza, Miguel, Lopez-Ibor, Blanca, Villalba, Maria, Lang, Frederick F, Fueyo, Juan, Gomez-Manzano, Candelaria, Dobbs, Jessica, Diez-Valle, Ricardo, Alonso, Marta M, Tejada, Sonia
Published in Neuro Oncol (2021)

A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool

by Manterola, Lorea, Guruceaga, Elizabeth, Pérez-Larraya, Jaime Gállego, González-Huarriz, Marisol, Jauregui, Patricia, Tejada, Sonia, Diez-Valle, Ricardo, Segura, Victor, Samprón, Nicolás, Barrena, Cristina, Ruiz, Irune, Agirre, Amaia, Ayuso, Ángel, Rodríguez, Javier, González, Álvaro, Xipell, Enric, Matheu, Ander, López de Munain, Adolfo, Tuñón, Teresa, Zazpe, Idoya, García-Foncillas, Jesús, Paris, Sophie, Delattre, Jean Yves, Alonso, Marta M.
Published 2014

Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

by Garcia-Moure, Marc, Gonzalez-Huarriz, Marisol, Labiano, Sara, Guruceaga, Elizabeth, Bandrés, Eva, Zalacain, Marta, Marrodan, Lucía, de Andrea, Carlos, Villalba, Maria, Martinez-Vélez, Naiara, Laspidea, Virginia, Puigdelloses, Montse, Perez-Larraya, Jaime Gallego, Iñigo-Marco, Ignacio, Stripecke, Renata, Chan, Jennifer A, Raabe, Eric H, Kool, Marcel, Gomez-Manzano, Candelaria, Fueyo, Juan, Patiño-García, Ana, Alonso, Marta M
Published in Clin Cancer Res (2021)